Aqr Capital Management LLC Amicus Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 88,846 shares of FOLD stock, worth $876,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,846

Previous 87,624 1.39%

Holding current value

$876,910

Previous $869,000 9.09%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $11,670 - $14,773	1,222 Added 1.39%	88,846 $948,000
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $30,934 - $40,208	-3,422 Reduced 3.76%	87,624 $869,000
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $101,098 - $125,952	-8,845 Reduced 8.85%	91,046 $1.07 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $115,133 - $167,676	-11,548 Reduced 10.36%	99,891 $1.42 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $108,694 - $127,886	-9,227 Reduced 7.65%	111,439 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $27,550 - $34,181	2,570 Added 2.18%	120,666 $1.52 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $37,966 - $47,119	3,480 Added 3.04%	118,096 $1.31 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $120,371 - $154,571	12,171 Added 11.88%	114,616 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $156,795 - $203,579	15,967 Added 18.46%	102,445 $1.07 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $15,032 - $26,832	-2,413 Reduced 2.71%	86,478 $929,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $522,753 - $1.36 Million	-56,821 Reduced 39.0%	88,891 $878,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $392,758 - $725,742	29,158 Added 25.02%	145,712 $3.36 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $285,242 - $351,629	-22,129 Reduced 15.96%	116,554 $1.65 Million
Q2 2020 Aug 17, 2020	SELL	$8.86 - $15.69 $56,978 - $100,902	-6,431 Reduced 4.43%	138,683 $2.09 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $43,758 - $73,656	-6,600 Reduced 4.35%	145,114 $1.34 Million
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $162,001 - $232,823	-21,658 Reduced 12.49%	151,714 $1.48 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $1,844 - $3,047	-230 Reduced 0.13%	173,372 $1.39 Million
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $116,393 - $161,374	11,593 Added 7.16%	173,602 $2.36 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $334,747 - $536,874	-39,946 Reduced 19.78%	162,009 $1.55 Million
Q3 2018 Nov 15, 2018	SELL	$11.6 - $16.54 $272,170 - $388,078	-23,463 Reduced 10.41%	201,955 $2.44 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $69,877 - $90,952	-5,322 Reduced 2.31%	225,418 $3.52 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $14,778 - $18,386	1,074 Added 0.47%	230,740 $3.47 Million
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $447,157 - $580,482	35,744 Added 18.43%	229,666 $3.31 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.28 Million - $3.06 Million	193,922	193,922 $2.92 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Amicus Therapeutics, Inc. Transaction History